The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Cytokine storm intervention in the early stages of COVID-19 pneumonia
Open accessAbstract
Clinical intervention in patients with corona virus disease 2019 (COVID-19) has demonstrated a strong upregulation of cytokine production in patients who are critically ill with SARS-CoV2-induced pneumonia. In a retrospective study of 41 patients with COVID-19, most patients with SARS-CoV-2 infection developed mild symptoms, whereas some patients later developed aggravated disease symptoms, and eventually passed away because of multiple organ dysfunction syndrome (MODS), as a consequence of a severe cytokine storm. Guidelines for the diagnosis and treatment of SARS-CoV-2 infected pneumonia were first published January 30th, 2020; these guidelines recommended for the first time that cytokine monitoring should be applied in severely ill patients to reduce pneumonia related mortality. The cytokine storm observed in COVID-19 illness is also an important component of mortality in other viral diseases, including SARS, MERS and influenza. In view of the severe morbidity and mortality of COVID-19 pneumonia, we review the current understanding of treatment of human coronavirus infections from the perspective of a dysregulated cytokine and immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“pro-inflammatory factors are intensely released, the so-called “cytokine storm”, which enter the bloodstream, and reach other organs (Fig. 1A) [9].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [9]
In the citing paper
“Cytokine storms have been reported in several viral infections [96], including SARS-CoV-2 [9, 97].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [9]
In the citing paper
“Patients infected with SARS-CoV-2 present elevated levels of IL-6, IL-10, IL-1β, INF-γ, CCL2, TNF-α, CXCL10, CCL7, IL-1 receptor antagonist and IL-2 receptor, supposedly associated with disease severity [9, 98–105].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Jin, Y., Cai, L., Cheng, Z., Cheng, H., Deng, T., Fan, Y., Fang, C., Huang, D., Huang, L., Huang, Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,306
Shimabukuro‐Vornhagen, A., Gödel, P., Subklewe, M. S., Stemmler, H., Schlößer, H., Schlaak, M. S., Kochanek, M., Böll, B., & von Bergwelt‐Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,712
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,428
Research works printed but not linked: 3
- Tian, 2020, Pulmonary pathology of early phase SARS-COV-2 pneumonia, Preprints
- Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585 · DOI · Paper page
- Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med., 10.1016/S2213-2600(20)30076-X · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 512
Pathogenic antibodies induced by spike proteins of COVID-19 and SARS-CoV virusesPreprint
Wang, H., Chen, Q., Hu, Y., Wu, X., Dai, L., Zhang, Y., Li, F., Lü, J., Chen, Y., & Liu, X. (2021) · Research Square · doi:10.21203/rs.3.rs-612103/v2 · Cited by 1
The aging whole blood transcriptome reveals a potential role of FASLG in COVID-19Preprint
Chuffa, L. G. D. A., Souza, J. D. S., de Mello, M. C., Neto, M. D. O., & Carvalho, R. F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.04.412494 · Cited by 1
新型コロナウイルス感染(SARS-CoV-2)と小児:新生児から思春期まで~抗リウマチ薬治療下にある小児リウマチ性疾患児は治療変更が必要か~
俊平, 横., 名古希実, 金田宜子, 土田博和, & 雅亮, 森. (2020) · 臨床リウマチ · doi:10.14961/cra.32.98
Plasmapheresis: A New Strategy in the Treatment of COVID-19
Kumar, P., Ahmad, M. I., & Singh, S. (2020) · Pharmaceutical Sciences · doi:10.34172/ps.2020.55
The contemporary role of point-of-care ultrasound amid a global health emergency: a critical review
McNab, O. (2020) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2020.0087
da Silva, K. N., Pinheiro, P. C. G., Gobatto, A. L. N., Passos, R. D. H., Paredes, B. D., França, L. S. D. A., Nonaka, C. K. V., Barreto‐Duarte, B., Araújo‐Pereira, M., dos Santos, R., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-132721/v1
A Proposal of Early Diagnosis and Early Management in Dengue Infection and Possible COVID-19
Arpornsuwan, M., & Arpornsuwan, M. (2020) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2020.00059
Balef, S. S. H., Karimi, Z., Azari, A., Sadraei, S. S., Hasanjani, P., Sadeghi, Y., Ahmadi, S., Qorbannejad, F., Farmoudeh, A., & Irannejad, H. (2021) · Anti-Infective Agents · doi:10.2174/2211352519666210217100423
Implications of the SARS-CoV-2 spike protein interaction with type-1 macrophages via α7-nAChR.Preprint
Saraiya, T., Labrou, D., Farsalinos, K. E., & Poulas, K. A. (2021) · doi:10.32388/26gtod.2
Corticosteroids for the Treatment of SARS-CoV2 Infection: Does It Work?
Shirvani, F., & Hashemieh, M. (2021) · International Journal of Infection · doi:10.5812/iji.110110
Trаtsiak, D. S., Abdin, K. A., Makarov, A. A., Трухан, А. П., Dobryanets, A. I., Vovk, V. A., Klosova, M. A., & Volchenko, O. V. (2021) · Novosti hirurgii · doi:10.18484/2305-0047.2021.1.62
Hayon, S. G. V., Priscilia, F., & -, H. (2021) · Journal of Community Empowerment for Health · doi:10.22146/jcoemph.60831
Shen, Y., Ba, Y., Hu, Y., Wang, L., & Li, W. (2020) · Research Square · doi:10.21203/rs.3.rs-84754/v1
Uso racional de tocilizumab en pacientes con COVID-19: una propuesta conciliadora
Flores-Franco, R. A. (2021) · NCT Neumología y Cirugía de Tórax · doi:10.35366/99460
COVID-19 Pathophysiology and Clinical Effects on Multiple Organ Systems - A Narrative Review
Bhatt, K. P., Quinonez, J., Patel, A., Patel, M. H., Mohamed, A., Aziz, M. A., Venkataramani, D., Zohora, F., Hange, N., Awad, D. H., et al. (2021) · International Annals of Science · doi:10.21467/ias.10.1.151-167
Pathogenic antibodies induced by spike proteins of COVID-19 and SARS-CoV virusesPreprint
Wang, H., Chen, Q., Hu, Y., Wu, X., Dai, L., Zhang, Y., Li, F., Lü, J., Chen, Y., & Liu, X. (2021) · Research Square · doi:10.21203/rs.3.rs-612103/v1
Role of Vascular Ultrasonography in COVID-19-- Review Article
Waseem, N., Abbas, B., Nazir, U., Waseem, H., Ali, A., & Zulfiqar, T. (2021) · Saudi Journal of Medicine · doi:10.36348/sjm.2021.v06i02.002
A clinical view on the covid-19 racial disparity in the u.s. and the u.k.
Herbert, E. (2020) · The Anatolian Journal of Family Medicine · doi:10.5505/anatoljfm.2020.84756
The role of high-dose steroid therapy in Covid-19 pneumoniaPreprint
Öztürk, A., Ergür, F. Ö., Kavurgacı, S., Şener, M. U., & Yıldız, M. (2021) · doi:10.22541/au.162699286.68650358/v1
The timing of natural killer cell response in coronavirus infection: a concise model perspectivePreprint
Xu, X., & Sneppen, K. (2021) · bioRxiv · doi:10.1101/2021.08.02.454730
Haneef, K., Saleem, R., Khan, M. S. I., Adeyinka, O. S., Banday, S., Asghar, M. U., Rahman, Z. U., & Fatima, Z. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00011
Acute kidney injury in a patient with COVID-19: Answers
Ozturk, T. T., Baltu, D., Şükür, E. D. K., Özsürekçi, Y., Güçer, Ş., Başaran, Ö., Gülhan, B., Özaltın, F., Düzova, A., & Topaloğlu, R. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05237-y
Prevalence of Hypothyroidism Among Patients With COVID-19, Tehran, IranPreprint
Esfahanian, F., SeyedAlinaghi, S., Janfaza, N., & Tantuoyir, M. M. (2021) · Research Square · doi:10.21203/rs.3.rs-858279/v1
COVID-19: DADOS EPIDEMIOLÓGICOS EM UM CENTRO DE REFERÊNCIA NA AMAZÔNIA
Pires, C. A. A., da Mota, N. R., Moreira, A. G., Abreu, J. C. S. M. D., Vallinoto, I. M. V. C., Cunha, A. C. D. S., & Monteiro, J. C. M. S. (2021) · doi:10.22533/at.ed.7372108106
AÇÕES TÉCNICAS E GERENCIAIS DE FISIOTERAPIA HOSPITALAR FRENTE À COVID-19: RELATO DE EXPERIÊNCIA
Ferreira, L. G. D. F., de Almeida, L. S. S., da Silva, E., Franco, V. D. S. P., Lustosa, J. B., Alves, A. M. M., de Figueirêdo, L. C., & Madeira, M. Z. D. A. (2021) · doi:10.22533/at.ed.7372108102
GESTANTES COVID-19 POSITIVO, TRABALHO DE PARTO, AMAMENTAÇÃO E RISCO DE TRANSMISSÃO VERTICAL
Vieira, B. C., Godoi, B. D. O., Alvino, C. C. D. M., dos Santos, E. C., Teixeira, J. G., da Silva, K. I. M., França, S. D. D. M., Nascente, F. M. N., de Oliveira, G. A., & Bontempo, A. P. D. S. (2021) · doi:10.22533/at.ed.73721081016
MANEJO INTRA-HOSPITALAR PERANTE A COVID-19: UMA REVISÃO NARRATIVA DA LITERATURA
Migon, L. B., Ribeiro, L. M. C., de Gouveia, N. M., & Assis, R. (2021) · doi:10.22533/at.ed.73721081019
Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders
Kardani, K., Bolhassani, A., Kardani, M., & Agi, E. (2021) · Journal of Medical Microbiology and Infectious Diseases · doi:10.52547/jommid.9.3.122
The risk factor for instability metabolic health and severity
Al-Koofee, D. A. F., Omara, A. M., Abulrazzaq, A. B., & Zaid, R. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.12.132
ОСОБЕННОСТИ ИММУННОГО РЕАГИРОВАНИЯ НА ВИРУС SARS-COV-2.Preprint
Алексеевна, Г. А., Николаевна, Т. А., Ponezheva, Z. B., Ивановна, А. Н., & Vv, M. (2020) · doi:10.21055/preprints-3111900
Perspectives Concerning Various Symptoms of SARS-CoV-2 Detected Individuals
Pasharawipas, T. (2021) · The Open Microbiology Journal · doi:10.2174/1874285802115010152
SARS-COV-2 Induce Pulmonary Injury from Basic to Clinical Research
Zhu, J. (2022) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2022.123018
Bakhtar, V., Bakhtar, N., Bakhtar, N., & Pandey, K. (2022) · Journal of Medicine in Scientific Research · doi:10.4103/jmisr.jmisr_70_21
Predicting mortality in critically ill COVID-19 patients in a low-resources settingPreprint
Vélez-Páez, J. L., Montalvo-Villagómez, M., González, F. E. J., Moscoso, S. X. A., Tercero-Martínez, W., Saltos, L. S., Jiménez-Alulima, G., Irigoyen-Mogro, E., Castro-Reyes, E. E., Mora-Coello, C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-315954/v1
Implications of the SARS-CoV-2 spike protein interaction with type-1 macrophages via α7-nAChR.Preprint
Saraiya, T., Farsalinos, K. E., Poulas, K. A., & Labrou, D. (2021) · doi:10.32388/26gtod
A narrative review of newly approved drugs for COVID-19Preprint
Seetharaman, R., & Lokhande, J. (2020) · doi:10.31219/osf.io/7f3qs
ANTICUERPOS MONOCLONALES PARA EL TRATAMIENTO DEL COVID-19
Arce-Rodríguez, N., Vargas, C. B., Campos, G. G., Vargas, E. M., Orlich, M. J. M., Villalobos, D. T., & Román, J. J. M. (2022) · Revista Médica de la Universidad de Costa Rica · doi:10.15517/rmucr.v16i1.50850
Kılıçkaya, R., Orak, Y., Orak, F., & Doğaner, A. (2022) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.1099333
Pulse dose glucocorticosteroid therapy in COVID-19 pneumonia patients in an intensive care unit
Ceylan, İ., Güler, G., Ökmen, K., Sayan, H. E., & Karakoç, E. (2022) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/12122
Hygiene in der Dermatologie: SARS-CoV-2 und weitere Virus-Varianten
Schlatterer, K., Maxeiner, H.-G., Zouboulis, C. C., & Daeschlein, G. (2022) · Aktuelle Dermatologie · doi:10.1055/a-1703-1692
Applications of nanoengineered therapeutics and vaccines: special emphasis on COVID-19
Mohamed, N. K., Hamad, M. A., Ghaleb, A. H., Esmat, G., & Elsabahy, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90604-3.00003-6
Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases
Zahedipour, F., Guest, P. C., Majeed, M. A., Al‐Rasadi, K., Jamialahmadi, T., & Sahebkar, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2395-4_20
Ali, S., Khan, O. S., Khalil, A. M., & Odeh, A. K. (2022) · Cureus · doi:10.7759/cureus.27021
Chen, Y., zhang, W., Yu, Y., Chen, X., Jiang, G., Ou, G., Liu, Q., Li, J., & Chen, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1838856/v1
Self-citationCOVID-19: PATHOGENESIS AND IMMUNOLOGICAL PERSPECTIVE
(2022) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2022/11.3.5930
Takahashi, K., Inoue, H., Kishimoto, M., Nakayama, R., Kasai, T., Bunya, N., Harada, K., Uemura, S., & Narimatsu, E. (2022) · Renal Replacement Therapy · doi:10.1186/s41100-022-00436-1
Covid-19: Consumption coagulopathy with increased severity and mortality - A retrospective study
Gaur, K., Natarajan, S., & Gupta, M. (2022) · IP Journal of diagnostic pathology and oncology/IP journal of diagnostic pathology and oncology/Journal of diagnostic pathology and oncology · doi:10.18231/j.jdpo.2022.039
Ishibashi, N., Maebayashi, T., Aizawa, T., Sakaguchi, M., & Okada, M. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14677
Comparative Analysis Of Immunosuppressive Therapy Effectiveness In COVID-19 Patients
Tyurin, A. V., Akhiiarova, K. E., Valishin, D. A., Данисовна, С. Л., Хусаинова, Л. Н., Zagidullin, N. S., Gantseva, K. K., & Павлов, В. Н. (2022) · Russian Open Medical Journal · doi:10.15275/rusomj.2022.0312
Chulanov, V., Бакиров, Б. А., Vezikova, N. N., Городин, В. Н., Zhuravleva, M. V., Игоревна, З. А., Ivanov, I., Lomakin, N. V., Lukina, G. V., Леонидовна, М. Д., et al. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.08.201788
Delen, L. A., Kasapoğlu, U. S., Gök, A., Çağaşar, Ö., Tetik, B., & Öksüz, E. (2022) · Marmara medical journal · doi:10.5472/marumj.1191126
The similarities between severe COVID-19 infection and acute radiation syndrome: Literature review
Yuliana, Y. (2022) · AIP conference proceedings · doi:10.1063/5.0127143
Antitumor Immunotherapy: Effect of COVID-19 in Cancer Patients
Shubina, I. Z., Chikileva, I. O., & Sokolov, N. Y. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_100
COVID-19 en pacientes con lupus eritematoso sistémico y mortalidad
Arroyo, N. V. A., Hernández-Sánchez, N., Gasca-Aldama, J. C., & Salvador-Ibarra, I. J. (2022) · Acta Médica Colombiana · doi:10.36104/amc.2022.2551
Can SARS-CoV-2 trigger a food allergy?
Falcão, I., & Cunha, L. (2022) · Arquivos de Asmas Alergia e Imunologia · doi:10.5935/2526-5393.20220049
Effect of Mast Cells in the Pathogenesis of COVID-19
Karaca, T. (2022) · Kocaeli Medical Journal · doi:10.5505/ktd.2022.45336
Proinflammatory and Thrombotic Manifestations and the Therapeutic Options of COVID-19
Daga, M. K., Chand, S., Kumar, N. P., Mawari, G., Raghu, R., & Aarthi, J. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815123371123030005
Hou, J., Kouznetsova, V. L., & Tsigelny, I. F. (2022) · Microbiology & Infectious Diseases · doi:10.33425/2639-9458.1145
Patel, H. S., Crilley, T. A., Srivastav, J., & Savage, P. D. (2022) · ACG Case Reports Journal · doi:10.14309/crj.0000000000000885
Inflammatory environment in patients with COVID-19
Ventura, I. (2023) · Nereis Interdisciplinary Ibero-American Journal of Methods Modelling and Simulation · doi:10.46583/nereis_2022.1.1036
Zinco e doenças respiratórias virais
Martins, M. D. C. D. C. E., Oliveira, A. S. D. S. S., & Sales, A. L. D. C. C. (2020) · Jornal de Ciências da Saúde do Hospital Universitário da Universidade Federal do Piauí · doi:10.26694/jcshuufpi.v3i4.794
The Pathogenetic Role of DAMPs in Severe Infectious Diseases
Land, W. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-21776-0_5
Yıldırım, F., Şimşek, M., Apaydın, M., Karaman, İ., & Dural, H. İ. (2023) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x19666230320164227
Estimating Time Window to Administer Anti-Cytokine Therapeutic Drugs to COVID-19 Patients
Pal, S., Misra, S., & Islam, N. (2023) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2023.3279016
Delen, L. A. (2022) · Acta Clinica Croatica · doi:10.20471/acc.2022.61.03.05
Sujalmo, P., Purwanto, R. Y., Rismawanti, R. I., Pratama, Y. Y., Lalitya, W., & Fachrudin, A. B. (2022) · Academic Hospital Journal · doi:10.22146/ahj.v4i1.71798
Effect of vitamin D level on COVID-19 and the risk of complications in children
Kocięba-Łaciak, A. (2023) · Pediatria Polska · doi:10.5114/polp.2023.128067
Joint damage in patients with COVID-19 in family medicine
Skvortsov, V. V., Akimochkin, G. S., & Matokhin, S. E. (2023) · Spravočnik vrača obŝej praktiki (Journal of Family Medicine) · doi:10.33920/med-10-2307-04
Cai, Z., & Li, L. (2023) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-023-00379-6
Hasibuan, B., Medison, I., & Anggrainy, F. (2023) · Jurnal Respirologi Indonesia · doi:10.36497/jri.v43i3.426
Qi, R., Li, S., Li, F., Mai, J., Wang, Y., Zhu, G., Zhang, D., Li, Z., Shen, H., Shen, J., et al. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300037
Santos, P. C. N., Lemes, U. D. P., & Rocha, T. O. (2023) · Brazilian Journal of Development · doi:10.34117/bjdv9n8-096
Hand conditions as sequelae of infection with COVID-19: a literature review
Koo, K. K.-H., Morris, J. R., Ansari, S. A., & Younis, F. (2023) · Journal of Hand Surgery (European Volume) · doi:10.1177/17531934231192832
THE PROGNOSTIC ROLE OF BLOOD INTERLEUKIN STUDIES IN CHILDREN WITH COVID-19
Musaelyan, O. A., Golubeva, M., Borisova, Y. V., Shaposhnikov, B. S., & Pogorelova, L. V. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.32974
[Sistema inmune innato e infección por SARS-CoV-2. Revisión sistemática].
Coutiño-Rodríguez, E. M. ́. D. R. (2023) · PubMed · doi:10.29262/ram.v70i3.1200
Investigating Spine and Spinal Cord Complications of COVID-19
Mousavi, S. R., Farrokhi, M. R., Kalani, N., Mosalanezhad, T., Karimi, F., Eilami, O., & Kazeminezhad, A. (2023) · Iranian Journal of Neurosurgery · doi:10.32598/irjns.9.21
Endoscopic diagnostics and treatment of esophagitis in patients after COVID-19
Chernekhovskaya, N. E., Korzheva, I. Y., Volova, A. V., Povalyaev, A. V., & Andreev, V. G. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-213-5-27-33
Muhammed, P., Smail, S. W., & Amin, K. (2023) · Journal of Zankoy Sulaimani - Part A · doi:10.17656/jzs.10945
Antoniou, T., McCormack, D., Tadrous, M., & Gomes, T. (2024) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.13004
Study of some immunological indicators for COVID-19 patients in Babylon city
Obed, A. N., Hamza, T. A., & Al-Sa’ady, A. T. (2024) · Review of Clinical Pharmacology and Pharmacokinetics - International Edition · doi:10.61873/getk6172
Joint damage among the patients with COVID-19 in nurse practice
Skvortsov, V. V., Matokhin, S. E., Akimochkin, G. S., & Karchevsky, A. A. (2024) · Meditsinskaya sestra · doi:10.29296/25879979-2024-04-10
Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection
Suki, B., Lorx, A., & Bartolák‐Suki, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18703-2.00003-7
Samaraey, A. F. S., & Khalaf, S. K. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24717102311
Kollath, D. R., Grill, F. J., Itogawa, A. N., Fabio-Braga, A. P., Morales, M. M., Shepardson, K. M., Bryant, M. L., Yi, J., Ramsey, M. L., Luberto, E. T., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00610-y
Li, F., Wang, Y., Jin, M., Li, H., Jin, Y., Hu, J., Zhang, X., Wu, C., & Wei, L. (2024) · Archives of Medical Science · doi:10.5114/aoms/178422
Sepehri, G., Fallah, Z., Fekri, M. S., Dalfardi, B., Dabiri, S., Daneshvar, H., & Najafzadeh, M. J. (2024) · Majallah-i dānishgāh-i ̒ulum-i pizishkī-i Kirmān. · doi:10.34172/jkmu.2024.40
The Cytokine Profile in Sudanese Patients Infected with COVID-19 in Kassala State, Eastern Sudan
Ramli, A. A., Hussien, M. O., Musa, A. O., Shanawaz, M. A., Bakri, E. O., Salim, J. B., Omer, A. A. M., Kheiralla, K. E. K., & Abuzeid, N. M. K. (2025) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-157285
Cytokine profiles and neurological manifestations in post-COVID syndrome
Desheva, Y., Muruzheva, Z., Tumashova, O., Shvedova, T., Kudar, P., Matveev, G., Koroleva, I., Leontieva, G., Lerner, A., Ponkratov, S., et al. (2025) · Exploration of Immunology · doi:10.37349/ei.2025.1003184 · Cited by 1
Ibrahim, M. A., Alzubaidi, M. A. K., & Mohammed, R. N. (2025) · Coronaviruses · doi:10.2174/0126667975345155250302172530
Bukhari, A. R., Rehman, Y. A., Ashraf, J., Nasir, A., & Hasan, Z. (2025) · Research Square · doi:10.21203/rs.3.rs-5180392/v1
Types of effects of SARS-CoV-2 on the human body: from coagulopathy to cytokine storm
Михайлович, Н. К., Yakovleva, S. A., Shrayner, E. V., Platonova, P. Y., Novikova, M., Tumas, A. S., Евгеньевна, В. Е., Lukichev, D. A., Sergeev, D., Хавкин, А. И., et al. (2025) · Vrach · doi:10.29296/25877305-2025-03-02
Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland
Leśniak, M., Borkowska, A., Kłos, K., Aleksandrowicz, K., Porębska, K., Kobza, D., Piwowarek, K. Ł., Plewka, K., Niemcewicz, M., Lutyńska, A., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1613629
Pathogenetic Predictors of Complications of the New Coronavirus Infection SARS-COV-2
Chepur, S. V., Nn, P., Chubar, O. V., Сергеевна, Б. Л., Litvinenko, I., Tjunin, M. A., Mjasnikova, I. A., & Пугач, В. А. (2025) · Biology Bulletin Reviews · doi:10.1134/s2079086425600110
Choudhari, O. K., SATYA, D., Soni, P., & Gupta, N. K. (2025) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2025v17i6.7058
Kjerulff, J. L., Bach, A., Væggemose, U., Skaarup, S. H., & Bøtker, M. T. (2022) · Figshare · doi:10.6084/m9.figshare.19497961
Liu, Y., Pan, Y., Yin, Y., Chen, W., & Li, X. (2021) · Figshare · doi:10.6084/m9.figshare.15064636
Liu, Y., Pan, Y., Yin, Y., Chen, W., & Li, X. (2021) · Figshare · doi:10.6084/m9.figshare.15064633
Liu, Y., Pan, Y., Yin, Y., Chen, W., & Li, X. (2021) · Figshare · doi:10.6084/m9.figshare.15064639
Metadata
- Authors
- Sun, X., Wang, T., Cai, D., Hu, Z., Chen, J., Liao, H., Zhi, L., Wei, H., Zhang, Z., Qiu, Y., Wang, J., & Wang, A.
- Affiliations
- Chinese People's Liberation Army (CN)
- Nanjing University of Chinese Medicine (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Corresponding author
- Wang, Jing
- Wang, Aiping
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Pages
- 38-42
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7182527
- OpenAlex
- W3019663170
- Cited by
- 513
- References
- 36
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 77 · 2022: 110 · 2021: 160 · 2020: 102
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- cytokine storm, COVID-19 pandemic, SARS-CoV-2, COVID-19 pneumonia, cytokine monitoring, multiple organ failure, immune dysregulation, cytokine production, mortality, SARS, MERS, influenza, antiviral therapy
- MeSH terms
- Betacoronavirus, Continuous Renal Replacement Therapy, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Adrenal Cortex Hormones, Antibodies, Monoclonal, Female, Humans, Male, Multiple Organ Failure, Pneumonia, Viral, Polyethylene Glycols, Recombinant Proteins, Retrospective Studies, Cytokines, Interferon-alpha, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
